Use of NICE-appraised medicines in the NHS in England

Published by:
NHS Digital
Last updated:
21 April 2015
Topic:
Health
Licence:
Open Government Licence

Summary

The National Institute for Health and Care Excellence (NICE) technology appraisal process assesses the clinical and cost effectiveness of new and existing drugs and treatments, and provides guidance on their use by the NHS. As part of the Pharmaceutical Price Regulation Scheme (PPRS) agreement which came into operation on 1 January 2009, the Department of Health (DH) and the Association of the British Pharmaceutical Industry agreed that the DH would review the variation in uptake of selected medicines in the NHS in England.

More from this publisher

All datasets from NHS Digital

Related datasets

Search

Data links

Link to the data Format File added Data preview
Publication HTML 21 April 2015 Not available
2012, Experimental Statistics XLS 21 January 2014 Not available

Contact

Enquiries

General Enquiries

Freedom of Information (FOI) requests

FOI Enquiries Freedom of information requests for this dataset

Edit this dataset

You must have an account for this publisher on data.gov.uk to make any changes to a dataset.

Sign in